Monkeypox vaccine ‘IMVANEX’ approved in Europe

Daily Current Affairs / Monkeypox vaccine ‘IMVANEX’ approved in Europe

Change Language English Hindi

Category : International Published on: July 27 2022

Share on facebook

The European Commission has approved a smallpox vaccine for use against monkeypox after the World Health Organization declared monkeypox a global health emergency.
Imvanex has been approved in the EU since 2013 for the prevention of smallpox.
It was also considered a potential vaccine for monkeypox because of the similarity between the monkeypox virus and the smallpox virus.
Monkeypox is less dangerous and contagious than smallpox, which was eradicated in 1980.
The first symptoms of monkeypox are fever, headaches, muscle pain and back pain during the course of five days.

IndiGo’s parent company has brought on ex-G20 Sherpa and former NITI Aayog CEO Amitabh Kant to its board, enhancing leadership expertise.
Read More....
A new Garcinia species discovered in Assam has been named Garcinia kusumae to honour Jatindra Sarma’s mother.
Read More....
Mashreq Bank of UAE received in-principle approval to open a banking unit in Gujarat’s GIFT City.
Read More....
The third Bharat Mobility Global Expo will showcase innovations in mobility and auto sector.
Read More....
The report outlines India’s potential in global chemical value chains and suggests strategic reforms.
Read More....
Gill scored 254+ in a Test innings, surpassing Virat Kohli’s previous high of 254*.
Read More....
MobiKwik’s broking arm can now operate in trading and settlement of equity markets.
Read More....
The gas giant is six times Jupiter’s mass and lies 400 light years away from Earth.
Read More....
SBI flagged fund diversion in RCom’s ₹48,216 crore loan, escalating legal risk for Anil Ambani.
Read More....
Sri Lanka becomes Starlink’s third South Asian market after Bhutan and Bangladesh.
Read More....

Monkeypox vaccine ‘IMVANEX’ approved in Europe